3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
18
Hematologic Neoplasms
10
Prostatic Neoplasms
9
Colorectal Neoplasms
9
Breast Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
8
Carcinoma, Non-Small-Cell Lung
7
Anatomic Stage I Breast Cancer AJCC v8
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Neoplasms
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Carcinoma
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Multiple Myeloma
3
Melanoma
3
Malignant Solid Neoplasm
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Mouth Neoplasms
2
Head and Neck Neoplasms
2
Interventions
Nivolumab
3
capivasertib
2
Gemcitabine
2
Cisplatin
2
tivozanib
1
regorafenib
1
niraparib
1
neratinib
1
lutetium Lu 177 dotatate
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
durvalumab
1
copanlisib
1
cemiplimab
1
axicabtagene ciloleucel
1
avasopasem manganese
1
Valproic Acid
1
Thioctic Acid
1
Taxes
1
Receptors, Interleukin-6
1
Radiosurgery
1
RNA-Seq
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Multiparametric Magnetic Resonance Imaging
1
Leucovorin
1
Lenalidomide
1
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Disease Progression
×
Practice Guidelines as Topic
×
1 year
×
Clear all
No trials found.